本文基于科技创新成果转化理论基础，从科技成果转化的流程、模式及其相关发展要素等方面对我国生物医药科技成果转化的制约因素进行全面分析，发现创新研发导向偏差、全国性知识网络转化不畅、专项资金支撑不足等是当前影响最为深刻的三大制约因素，据此提出应增强政府政策的针对性和实效性、提升国家创新体系的成果转化效能、全方位打造多层次科技成果转化金融体系等战略规划建议。

Based on the relevant theories of the transformation of scientific and technological innovation achievements, this paper comprehensively analyzes the restrictive factors of the commercialization of biopharmaceutical research and development in China from the aspects of the process, model and relevant development factors of the commercialization of biopharmaceutical research and development, and finds that the deviation of the orientation of innovation research and development, the poor commercialization of the national knowledge network, and the lack of special fund support are the three most profound restrictive factors at present. Based on this, it is proposed to strengthen the pertinence and effectiveness of government policies, improve the efficiency of achievements commercialization of the national innovation system, and comprehensively build a multi-level financial system for scientific and technological achievements commercialization.

上海市2021年度科技创新行动计划软科学重点项目“上海重点领域创新链、供应链韧性研究-以生物医药领域为例”(项目编号:21692100400)。